NEW YORK (GenomeWeb) – Hologic said today that the World Health Organization has granted prequalification status for its CE-marked Aptima HIV-1 Quant Dx, the first HIV-1 viral load assay with a dual claim for both diagnosis and treatment monitoring.

Prequalification status means that the assay meets the WHO's standards of quality, safety, performance, and reliability, and other global health organizations can consider it for public-sector procurement in resource-limited countries.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.